43 research outputs found

    Diabetes in California: Findings From the 2001 California Health Interview Survey

    Get PDF
    Examines the prevalence of diabetes in California, with particular attention paid to disparities between different population groups. Includes access to medical care, diabetes care and management, and identifying at-risk populations

    Unveiling SEER-CAHPS®: A New Data Resource for Quality of Care Research

    Full text link
    BACKGROUND: Since 1990, the National Cancer Institute (NCI) and Centers for Medicare and Medicaid Services (CMS) have collaborated to create linked data resources to improve our understanding of patterns of care, health care costs, and trends in utilization. However, existing data linkages have not included measures of patient experiences with care. OBJECTIVE: To describe a new resource for quality of care research based on a linkage between the Medicare Consumer Assessment of Healthcare Providers and Systems (CAHPS®) patient surveys and the NCI’s Surveillance, Epidemiology and End Results (SEER) data. DESIGN: This is an observational study of CAHPS respondents and includes both fee-for-service and Medicare Advantage beneficiaries with and without cancer. The data linkage includes: CAHPS survey data collected between 1998 and 2010 to assess patient reports on multiple aspects of their care, such as access to needed and timely care, doctor communication, as well as patients’ global ratings of their personal doctor, specialists, overall health care, and their health plan; SEER registry data (1973–2007) on cancer site, stage, treatment, death information, and patient demographics; and longitudinal Medicare claims data (2002–2011) for fee-for-service beneficiaries on utilization and costs of care. PARTICIPANTS: In total, 150,750 respondents were in the cancer cohort and 571,318 were in the non-cancer cohort. MAIN MEASURES: The data linkage includes SEER data on cancer site, stage, treatment, death information, and patient demographics, in addition to longitudinal data from Medicare claims and information on patient experiences from CAHPS surveys. KEY RESULTS: Sizable proportions of cases from common cancers (e.g., breast, colorectal, prostate) and short-term survival cancers (e.g., pancreas) by time since diagnosis enable comparisons across the cancer care trajectory by MA vs. FFS coverage. CONCLUSIONS: SEER-CAHPS is a valuable resource for information about Medicare beneficiaries’ experiences of care across different diagnoses and treatment modalities, and enables comparisons by type of insurance

    Patient-Provider Communication During Posttreatment Breast Cancer Care: Findings From a Kaiser Permanente Northern California Pilot Project

    No full text
    Background: Patient-provider communication is essential to delivering high-quality cancer care, including posttreatment when survivors have many complex care needs. In this study, we used data collected for quality improvement from a small feasibility sample to examine patient perceptions of provider communication and inform the development of a new Oncology Survivorship Clinic model. Methods: As part of a pilot project conducted at Kaiser Permanente Northern California, we surveyed 51 breast cancer patients posttreatment. The survey included a communication measure from the 2011 Medical Expenditure Panel Survey: Experiences with Cancer Survivorship Supplement evaluating provider discussions of: 1) surveillance for recurrence, 2) late or long-term treatment effects, 3) healthy lifestyle behaviors, and 4) emotional or social needs. We also examined reports of the 6 core functions of patient-centered communication (ie, managing uncertainty, responding to emotions, making decisions, fostering healing relationships, enabling self-management, exchanging information) using a measure from the Health Information National Trends Survey 4: Cycle 4. Part of the purpose was to evaluate acceptability of a new Oncology Survivorship Clinic utilizing nonphysician providers. Results: The sample included 51 breast cancer patients surveyed in 2016 within 6 months of treatment completion. All women were stage 0–3. Overall, sizable proportions received detailed communication about surveillance (65%), treatment side effects (46%), emotional needs (41%) and healthy lifestyles (71%), and the majority received patient-centered communication (range: 60%–73% based on core function). Particular gaps were noted related to provider communication about treatment side effects (54%), emotional/social needs (59%), managing uncertainty (35%) and responding to emotions (40%). Conclusion: Our very preliminary findings suggest that the majority of women had positive communication experiences, including with nonphysician providers. However, clear communications gaps existed, underscoring future avenues for research and care delivery interventions to address the needs of breast cancer patients more comprehensively
    corecore